For years, some clinicians have been telling their patients to use a 5α-reductase inhibitors (5-ARIs) like finasteride or dutasteride as a form of “bridge” therapy to extend their periods of time off primary hormone therapy while being treated with intermittent hormone therapy or IHT. … READ MORE …
Filed under: Uncategorized | Tagged: 5-ARI, finasteride, IHT, intermiottent hormone therapy | 8 Comments »
Search for new and
ongoing trials on the
CTAG PCa web site
